1% Lidocaine HCL Injection By Hospira: Recall - Presence Of Dark Particulate

May result in local inflammation, phlebitis, and/or low-level allergic response, and could block administration of the drug to the patient, causing a delay in therapy.

 
comments powered by Disqus